dan barouch award

Best Academic Research Team, Vaccine Industry Excellence Award, World Vaccine Congress 2019

/in

Dr. Dan Barouch accepts the Best Academic Research Team, Vaccine Industry Excellence Award, World Vaccine Congress 2019 in Washington D.C., on April 15th 2019

A New Weapon Against HIV

/in

Dr.Barouch spoke to Discover Magazine about a promising candidate for an HIV vaccine raises hopes. Read Article

World’s Second Man Cleared of AIDS Virus Invigorates Quest for Cure

/in

Scientific investigation into the world’s second man cleared of the AIDS virus is zooming in on a gene and a treatment side-effect, as newly-enthused researchers strive to find a cure for the disease that has killed millions.

HIV Vaccines with Dan Barouch

/in

Dr. Dan Barouch discusses the challenges in designing an HIV vaccine and the ongoing clinical trials with vaccine research at BIDMC.
[Podcast]

red ribbon

NIH Statement on World AIDS Day

/in

“We are optimistic that an end to the HIV pandemic is feasible. However, to reach this goal, we must apply the tools and advances already at hand as we continue to follow the science in laboratories and clinics around the world. Today we honor the achievements of dedicated researchers, health care professionals, clinical trial participants and members of the global community, and we reaffirm our commitment to work together to fill the remaining gaps. [NIH news]

graph

HIV vaccine on horizon as jab triggers immunity in humans and stops monkeys being infected

/in

graph“We eagerly await the results of the phase 2b Imbokodo’, which will determine whether or not this vaccine will protect humans against acquiring HIV.”

HIV vaccine shows promise in human trial

/in


“An HIV vaccine that has the potential to protect people around the world from the virus has shown promising results.”
“These results represent an important milestone,” said Dan Barouch, professor of medicine at Harvard Medical School and lead author of the study.
[BBC News]

vials

Fifth HIV Vaccine Concept Tested for Efficacy in Humans

/in

“Although these data are promising, we need to remain cautious,” study leader Dan Barouch, a Harvard Medical School professor, told AFP. “This is only the fifth HIV vaccine concept that will be tested for efficacy in humans in the 35+ year history of the global HIV epidemic,” added Barouch. [Yahoo News]

Dan Barouch

HIV Vaccine One Step Closer According to Harvard Study

/in

“Dr. Dan Barouch, Professor of Medicine at Harvard Medical School and author of the study, told Newsweek he is “cautiously optimistic” about the results, but stressed there are many obstacles to overcome before a vaccine is rolled out for humans”

To Read More: [Newsweek article]

Scientists cautiously optimistic about HIV vaccine candidate

/in

baby“I would say that we are pleased with these data so far, but we have to interpret the data cautiously,” said study co-author Dr. Dan H. Barouch, a principal investigator on the study, a professor of medicine at Harvard Medical School and the director of the Center for Virology and Vaccine Research. “We have to acknowledge that developing an HIV vaccine is an unprecedented challenge, and we will not know for sure whether this vaccine will protect humans.” [CNN article]